Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Theranos Settles Separate Cases With CMS, Arizona Attorney General

Theranos Settles Separate Cases With CMS, Arizona Attorney General

Apr 18, 2017
|
staff reporter

NEW YORK (360Dx) — Theranos said late Monday that it reached a deal with the Centers for Medicare & Medicaid Services to settle all outstanding legal and regulatory proceedings against the firm.

Separately, the firm today said it will reimburse Arizona residents $4.65 million for blood testing services that it performed between 2013 and 2016. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. BD Gets CE-IVD Mark for Point-of-Care Coronavirus Antigen Test

  2. FDA Grants Emergency Use Authorizations to DiaSorin, NanoEntek, Nirmidas Coronavirus Antibody Tests

  3. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark

  4. BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test

  5. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.